December 18, 1998 - 4:46 p.m.
Isis Acquires Antisense Patent and Technology Estate from Gilead Sciences
Printer Friendly Version 
October 28, 1998 - 4:33 p.m.
Gilead Announces Third Quarter 1998 Financial Results
Printer Friendly Version 
September 24, 1998 - 4:20 p.m.
Gilead announces that partner Hoffmann-La Roche discloses GS 4104 Phase III study results
Printer Friendly Version 
September 23, 1998 - 4:10 p.m.
Gilead Sciences Provides Update on PREVEON® Clinical Program for the Treatment of HIV
Printer Friendly Version 
September 04, 1998 - 3:32 p.m.
Gilead Sciences Begins Phase II Human Testing of Oral PMPA for Treatment of HIV; Combinations Including Hydroxyurea to be Evaluated
Printer Friendly Version 
July 30, 1998 - 3:12 p.m.
Gilead Announces Second Quarter 1998 Financial Results
Printer Friendly Version 
June 30, 1998 - 3:06 p.m.
Gilead Announces Preliminary Results From Phase II/III Studies for New Product to Treat or Prevent Influenza
Printer Friendly Version 
June 26, 1998 - 2:49 p.m.
Gilead Sciences Announces Termination of Genetic Code Blocker Research Collaboration with Glaxo Wellcome
Printer Friendly Version 
June 15, 1998 - 1:16 p.m.
12th World Aids Conference To Be Broadcast On World Wide Web
Printer Friendly Version 
April 30, 1998 - 1:13 p.m.
Dr. Paul Berg Joins Gilead Sciences Board of Directors
Printer Friendly Version 
April 30, 1998 - 12:40 p.m.
Gilead Announces First Quarter 1998 Financial Results
Printer Friendly Version 
April 28, 1998 - 12:26 p.m.
Gilead Announces Adefovir Dipivoxil Reduces Hepatitis B Levels by More than 99 Percent in Chronically Infected Patients
Printer Friendly Version 
April 02, 1998 - 12:00 p.m.
Gilead Broadens HIV Expanded Access Program for PREVEON®
Printer Friendly Version 
March 10, 1998 - 11:55 a.m.
Cidofovir Reported to Have Activity Against Poxvirus Infection in Primates
Printer Friendly Version 
February 12, 1998 - 11:34 a.m.
Flu Patients in United States May Now Have Access to Experimental Oral Treatment for Influenza
Printer Friendly Version 
January 29, 1998 - 11:23 a.m.
Gilead Announces Fourth Quarter and 1997 Year-end Financial Results
Printer Friendly Version 
January 26, 1998 - 5:29 p.m.
Gilead Announces Presentation of Phase I/II Study Results of Oral PMPA for HIV at Upcoming Medical Conference
Printer Friendly Version 
NASDAQ (US Dollar)
$66.25
 Stock is Up 0.32 (0.49%)
Data as of 04/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote